| Serial Number | 79404811 |
| Word Mark | LINEARIS |
| Filing Date | Tuesday, June 18, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, August 13, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Providing analysis, evaluation, and reporting of cancer test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of diabetes test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of antimicrobial resistance test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis; providing medical information in the treatment and prevention of metabolic diseases and disorders; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing cancer screening services; diabetes screening services; medical screening services relating to cardiovascular disease; medical screening services relating to metabolomic diseases; providing information in the field of general health and wellness via a website; providing information relating to health and wellness, namely, diabetes; omics medical analysis services for cancer diagnostic provided by medical laboratories and treatment monitoring purposes to measure toxicity of treatment and response of treatment; proteomic and metabolomics medical analysis services for diabetes and antimicrobial resistance, diagnosis and treatment; medical screening; providing information relating to the preparation and dispensing of medications; pharmaceutical and drug review services of others, namely, review and analysis of toxicity of treatments and response to treatments in organs on a chip and non-human models; medical analysis services for diagnostic and treatment purposes provided by medical laboratories using diagnostic biomarkers for use in assessment of genomic, proteomic and metabolomics analysis for scientific, education and clinical use; remote monitoring of medical data for medical diagnosis and treatment; analysis and processing of blood plasma, stem cells, red blood cells, white blood cells, blood platelets and urine being medical services |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 19, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | LINEARIS LABS INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CA |
| Event Date | Event Description |
| Thursday, September 19, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, September 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 6, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, September 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, December 19, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, January 7, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, February 14, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, February 14, 2025 | REFUSAL PROCESSED BY MPU |
| Saturday, March 8, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, August 13, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 13, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 13, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |